Ozenoxacin
Back to searchMolecule Structure
Scientific Name
Ozenoxacin
Description of the Drug
Ozenoxacin is a quinolone antibiotic used to treat impetigo caused by susceptible bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12924
http://www.drugbank.ca/drugs/DB12924
Brand Name(s)
Xepi
Company Owner(s)
Ferrer Internacional Sa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL3038508 |
| DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL3038482 |
| DNA topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL3991503 |
| DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL3991502 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1711829 | |
| DrugBank | DB12924 | |
| PubChem: Thomson Pharma | 14828417 | |
| PubChem | 9863827 | |
| Nikkaji | J1.697.283E | |
| DrugCentral | 5058 | |
| ChemicalBook | CB62498834 | |
| Guide to Pharmacology | 10841 | |
| rxnorm | OZENOXACIN | XEPI |
| ChEBI | 136050 | |
| ZINC | ZINC000001483896 |
